Innovate UK has up to £6 million to invest in technologies that will help businesses to understand and meet the challenges involved in developing personalised medicines.
What is precision medicine?
Precision medicine refers to better targeting of treatments to patients by combining clinical knowledge with advances in diagnostic techniques and data analysis. It is often called stratified or personalised medicine.
By delivering the right treatments to the right patients in the right way it should create better results.
Organisations can apply for funding for feasibility studies and research and development projects.
Feasibility studies could include:
helping healthcare providers understand the attractiveness of a concept including by determining patient and user needs, required changes to patient pathways, commissioning and procurement options, health economics and adoption drivers
technical activities in areas such as developing prototypes and proofs of concept, collecting further data on use of biomarkers, and refining algorithms to improve patient stratification
assessing technical success in areas such as analytical performance, and diagnostic sensitivity and specificity
determining what information will need to be collated from a regulatory or health technology assessment
Research and development projects could focus on decision-making or take one or more of the following approaches:
developing tools to better integrate informatics and data
establishing precision medicine clinical trials
developing rapid diagnostics to inform better treatment decisions